Deutsches Herzzentrum der Charité, Department vor cardio-thoracic and vascular surgery
Berlin, State of Berlin, 13353, Germany
Location status: Recruiting
NCT Number: NCT07673536
This study will analyze extracellular vesicle (EV)-derived protein profiles in heart transplantated patients during the first 15 months post-transplantation to investigate, if there are distinct EV-derived proteins or protein patterns that allow early and reliable diagnosis of acute cardiac allograft rejection. Additionally, it will explore temporal changes in the EV-derived protein profile during the early postoperative period irrespective of acute allograft rejection, and will investigate, if there are correlations between EV protein markers and imaging findings.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Berlin, State of Berlin, 13353, Germany
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From entrollment to the end of study participation at 15 months
Change of the level of at least one EV-derived biomarker in the blood plasma of cardiac allograft recipients with endomyocardial biopsy-proven acute cellular or antibody-mediated cardiac allograft rejection compared to those with no rejection at the time of blood sampling.
Contact information is provided by the study sponsor or research team.
Laurenz Kopp Fernandes
Other
Acronym: ExoRejeCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06774365
HLA Antigens, Heart Transplantation
Bari, Italy
View Trial DetailsNCT06740578
Heart Transplantation, Rejection Heart Transplant
Paris, France
View Trial Details